<PubmedArticle>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">21671458</PMID>
<DateCompleted>
<Year>2012</Year>
<Month>07</Month>
<Day>16</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1098-108X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>45</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2012</Year>
<Month>Apr</Month>
</PubDate>
</JournalIssue>
<Title>The International journal of eating disorders</Title>
<ISOAbbreviation>Int J Eat Disord</ISOAbbreviation>
</Journal>
<ArticleTitle>Serotonin transporter binding after recovery from bulimia nervosa.</ArticleTitle>
<Pagination>
<MedlinePgn>345-52</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/eat.20944</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Physiological and pharmacological studies indicate that altered brain serotonin (5-HT) activity could contribute to a susceptibility to develop appetitive and behavioral alterations that are characteristic of bulimia nervosa (BN).</AbstractText>
<AbstractText Label="METHOD" NlmCategory="METHODS">Eight individuals recovered from BN (REC BN) and eight healthy control women were scanned with [11C]DASB and positron emission tomography imaging of the 5-HT transporter (5-HTT). Logan graphical analysis was applied, and parametric binding potential (BP(nondisplaceable (ND)) ) images were generated. Voxel-by-voxel t-tests and a region of interest (ROI) analysis were conducted.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">REC BN had significantly lower [11C]DASB BP(ND) in midbrain, superior and inferior cingulate and significantly higher [11C]DASB BP(ND) in anterior cingulate and superior temporal gyrus in the voxel-based analysis. ROI analysis indicated lower [11C]DASB BP(ND) in midbrain (p = .07), containing the dorsal raphe, in REC BN, consistent with our earlier studies.</AbstractText>
<AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">These preliminary findings of a small-scale study confirm and extend previous data suggesting that ill and recovered BN have altered 5-HTT measures, which potentially contribute to BN symptomatology and/or differential responses to medication.</AbstractText>
<CopyrightInformation>Copyright Â© 2011 Wiley Periodicals, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Pichika</LastName>
<ForeName>Rama</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Radiology, University of California, San Diego, California, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Buchsbaum</LastName>
<ForeName>Monte S</ForeName>
<Initials>MS</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bailer</LastName>
<ForeName>Ursula</ForeName>
<Initials>U</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hoh</LastName>
<ForeName>Carl</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Decastro</LastName>
<ForeName>Alex</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Buchsbaum</LastName>
<ForeName>Bradley R</ForeName>
<Initials>BR</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kaye</LastName>
<ForeName>Walter</ForeName>
<Initials>W</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>K05 MH001894</GrantID>
<Acronym>MH</Acronym>
<Agency>NIMH NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>MH004298</GrantID>
<Acronym>MH</Acronym>
<Agency>NIMH NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>K05-MH001894</GrantID>
<Acronym>MH</Acronym>
<Agency>NIMH NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 MH046001</GrantID>
<Acronym>MH</Acronym>
<Agency>NIMH NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>MH046001</GrantID>
<Acronym>MH</Acronym>
<Agency>NIMH NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 MH042984</GrantID>
<Acronym>MH</Acronym>
<Agency>NIMH NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>K05 MH001894-05</GrantID>
<Acronym>MH</Acronym>
<Agency>NIMH NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 MH092793</GrantID>
<Acronym>MH</Acronym>
<Agency>NIMH NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 MH046001-15</GrantID>
<Acronym>MH</Acronym>
<Agency>NIMH NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2011</Year>
<Month>06</Month>
<Day>13</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Int J Eat Disord</MedlineTA>
<NlmUniqueID>8111226</NlmUniqueID>
<ISSNLinking>0276-3478</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D050486">Serotonin Plasma Membrane Transport Proteins</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000000981">diagnostic imaging</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D052018">Bulimia Nervosa</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000000981">diagnostic imaging</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011877">Radionuclide Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050486">Serotonin Plasma Membrane Transport Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="accepted">
<Year>2011</Year>
<Month>04</Month>
<Day>16</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2011</Year>
<Month>6</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2011</Year>
<Month>6</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2012</Year>
<Month>7</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">21671458</ArticleId>
<ArticleId IdType="doi">10.1002/eat.20944</ArticleId>
<ArticleId IdType="pmc">PMC3175264</ArticleId>
<ArticleId IdType="mid">NIHMS291437</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>J Cereb Blood Flow Metab. 2001 Nov;21(11):1342-53</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11702049</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Psychiatry. 2001 Jul;158(7):1152-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11431241</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nucl Med Biol. 2003 Nov;30(8):833-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14698787</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Nucl Med. 2004 Apr;45(4):682-94</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15073266</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Gen Psychiatry. 1989 Nov;46(11):1006-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2684084</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Gen Psychiatry. 1989 Nov;46(11):1012-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2510699</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Psychiatry. 1991 Oct;52 Suppl:34-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1938987</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Nucl Med. 1995 Sep;36(9):1714-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7658236</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Cereb Blood Flow Metab. 1996 Sep;16(5):834-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8784228</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Gen Psychiatry. 1998 Oct;55(10):927-35</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9783564</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Affect Disord. 1998 Dec;51(3):215-35</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10333979</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biol Psychiatry. 1999 May 15;45(10):1285-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10349034</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Eat Disord. 2005 Jan;37(1):57-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15690467</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neuropsychopharmacology. 2005 May;30(5):1028-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15841087</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Gen Psychiatry. 2005 Sep;62(9):1032-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16143735</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Eat Disord. 2005 Nov;38(3):244-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16211626</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biol Psychiatry. 2006 Feb 1;59(3):291-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16139807</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biol Psychiatry. 2006 May 1;59(9):821-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16213473</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Nucl Med. 2006 May;47(5):815-26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16644752</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Psychiatry Neurosci. 2007 Mar;32(2):86-102</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17353938</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Eat Disord. 2007 May;40(4):381-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17286246</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Synapse. 2007 Sep;61(9):724-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17559093</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Cereb Blood Flow Metab. 2007 Sep;27(9):1533-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17519979</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biol Psychiatry. 2007 Oct 15;62(8):870-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17678634</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychopharmacology (Berl). 2007 Dec;195(3):315-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17690869</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Gen Psychiatry. 2008 Sep;65(9):1072-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18762593</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Nucl Med Mol Imaging. 2009 May;36(5):841-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19183998</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Neurosci. 2009 Aug;10(8):573-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19603056</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biol Psychiatry. 2010 Jun 1;67(11):1033-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20110086</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Eat Disord. 2011 Sep;44(6):477-87</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20872754</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychopharmacology (Berl). 2001 May;155(3):310-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11432694</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biol Psychiatry. 2001 Feb 15;49(4):326-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11239903</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neuroimage. 2002 Oct;17(2):825-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12377157</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</PubmedArticle>